Skip to content
Disclosery

Cravens & Co Advisors, LLC: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Cravens & Co Advisors, LLC on GSK, newest first. How the timeline and the estimate are built.

Cravens & Co Advisors, LLC held 7,400 GSK shares at 2026-06-30 per its 13F-HR filed 2026-08-12.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 7,400 shares
    Change vs previous 13F -351 shares

    0.26% of the 13F portfolio, value $387,908.

    13F-HR 0001966116-26-000003 filed by Cravens & Co Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 7,751 shares
    Change vs previous 13F +184 shares

    0.28% of the 13F portfolio, value $427,778.

    13F-HR 0001966116-26-000002 filed by Cravens & Co Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 7,567 shares
    Change vs previous 13F -189 shares

    0.25% of the 13F portfolio, value $377,593.

    13F-HR 0001966116-26-000001 filed by Cravens & Co Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 7,756 shares
    Change vs previous 13F -3 shares

    0.23% of the 13F portfolio, value $334,749.

    13F-HR 0001966116-25-000006 filed by Cravens & Co Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 7,759 shares
    Change vs previous 13F +170 shares

    0.22% of the 13F portfolio, value $297,946.

    13F-HR 0001966116-25-000004 filed by Cravens & Co Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 7,589 shares
    Change vs previous 13F +7,589 shares

    0.23% of the 13F portfolio, value $293,998.

    13F-HR 0001966116-25-000003 filed by Cravens & Co Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 0 shares
    Change vs previous 13F -7,459 shares

    13F-HR 0001966116-25-000001 filed by Cravens & Co Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  8. period ended2024-09-30
    13F 7,459 shares
    Change vs previous 13F not available

    0.24% of the 13F portfolio, value $304,924.

    13F-HR 0001966116-24-000005 filed by Cravens & Co Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).